The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 435.00
Ask: 445.00
Change: 15.00 (3.53%)
Spread: 10.00 (2.299%)
Open: 425.00
High: 445.00
Low: 425.00
Prev. Close: 425.00
MPAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

10 Jun 2022 16:10

RNS Number : 5308O
Mpac Group PLC
10 June 2022
 

10 June 2022

 

Mpac Group plc

 

(the "Company" or the "Group")

 

Grant of Options

 

Director/PDMR Transaction

 

The Company announces that, on 10 June 2022, it awarded a total of 187,740 options to subscribe for new ordinary shares in the Company under the Mpac Group plc Long Term Incentive Plan ("LTIP") 2019 to certain of the Company's Directors/PDMRs in the amounts set out below (the "LTIP Options").

 

Director/PDMR

Number of LTIP Options

Tony Steels, Chief Executive Officer

96,552

Will Wilkins, Group Finance Director

37,548

Mike Brown, Regional Director Americas

26,820

Adam Ward, Regional Director EMEA

26,820

 

 

The LTIP Options are exercisable at the nominal price of £0.25 and have vesting conditions tied to cumulative Earnings Per Share (EPS) and average Return On Capital Employed (ROCE), with each award split equally between the two performance conditions. Cumulative EPS has to exceed 180p over the performance period to vest in full. Vesting is reduced to 20% on a pro-rata basis if cumulative EPS is 140p over the performance period and is reduced to nil if below 140p. Average ROCE has to exceed 40% to vest in full. Vesting is reduced to 20% on a pro-rata basis if average ROCE is 30% over the performance period and is reduced to nil if below 30%.

 

The performance period will be 1 January 2022 to 31 December 2024 and, to the extent vested, the options will be subject to a two-year holding period following the expiry of the performance period.

 

 

For further information, please contact:

Mpac Group plc

Tony Steels, Chief Executive

Will Wilkins, Group Finance Director

 

 

Tel: +44(0)24 7642 1100

Shore Capital (Nominated Adviser & Broker)

Advisory

Patrick Castle

Iain Sexton

Broking

Henry Willcocks

 

Tel: +44(0)20 7408 4050

 

Hudson Sandler

Nick Lyon / Nick Moore

Tel: +44(0)20 7796 4133

 

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tony Steels

2

Reason for the notification

a)

Position/status

PDMR - Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options for ordinary shares exercisable at £0.25

GB0005991111

b)

Nature of the transaction

Grant of options under the Mpac Group plc Long-Term Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

n/a

 96,552

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

10 June 2022

f)

Place of the transaction

n/a

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Will Wilkins

2

Reason for the notification

a)

Position/status

PDMR - Group Finance Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options for ordinary shares exercisable at £0.25

GB0005991111

b)

Nature of the transaction

Grant of options under the Mpac Group plc Long-Term Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

n/a

 37,548

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

10 June 2022

f)

Place of the transaction

n/a

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Brown

2

Reason for the notification

a)

Position/status

PDMR - Regional Director Americas

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options for ordinary shares exercisable at £0.25

GB0005991111

b)

Nature of the transaction

Grant of options under the Mpac Group plc Long-Term Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

n/a

 26,820

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

10 June 2022

f)

Place of the transaction

n/a

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Ward

2

Reason for the notification

a)

Position/status

PDMR - Regional Director EMEA

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options for ordinary shares exercisable at £0.25

GB0005991111

b)

Nature of the transaction

Grant of options under the Mpac Group plc Long-Term Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

n/a

 26,820

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

10 June 2022

f)

Place of the transaction

n/a

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFMMATMTMBBLT
Date   Source Headline
26th Apr 20247:35 amRNSSiSTEM pilot battery assembly line
17th Apr 20247:00 amRNSLaunch of ESG Report
9th Apr 20241:12 pmRNSGrant of Options
8th Apr 20242:15 pmRNSNotice of AGM
19th Mar 20247:00 amRNSFull Year Results
21st Feb 20247:00 amRNSEquity Development Investor Presentation
16th Feb 20247:00 amRNSNotice of Results
11th Jan 20247:00 amRNSFull Year Trading Update
4th Dec 202311:51 amRNSDirector/PDMR Shareholding
27th Nov 202311:36 amRNSDirector/PDMR Dealing
18th Oct 20232:42 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSAppointment of Joint Broker
22nd Sep 202311:19 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSHalf Year Results
17th Aug 20237:00 amRNSEquity Development Investor Webinar
11th Jul 20237:00 amRNSTrading Update and Notice of Results
30th May 202310:52 amRNSDirector/PDMR Shareholding
18th May 202311:17 amRNSResult of Annual General Meeting
17th May 20237:00 amRNSAGM Statement
2nd May 20234:37 pmRNSDirector/PDMR Transaction
6th Apr 20235:30 pmRNSAvailability of Annual Report and Notice of AGM
27th Mar 202310:53 amRNSDirector/PDMR Dealing
22nd Mar 20237:01 amRNSCEO succession
22nd Mar 20237:00 amRNSFull Year Results
20th Feb 20237:00 amRNSEquity Development Investor Presentation
17th Feb 20237:00 amRNSNotice of Results
16th Jan 20237:00 amRNSFull Year Trading Update
24th Oct 20222:20 pmRNSDirectorate Appointment
14th Oct 202210:58 amRNSReplacement - PDMR Dealing & Total Voting Rights
12th Oct 20224:59 pmRNSDirector/PDMR Dealing & Total Voting Rights
15th Sep 202212:50 pmRNSMpac signs FREYR framework agreement
13th Sep 20227:00 amRNSEquity Development Investor Presentation
9th Sep 20222:16 pmRNSDirector/PDMR Transaction
8th Sep 20227:00 amRNSHalf Year Result
11th Jul 20227:00 amRNSTrading Update and Notice of Results
24th Jun 20222:54 pmRNSAppointment of new auditor
10th Jun 20224:10 pmRNSGrant of Options
27th May 20222:56 pmRNSDirectors/PDMRs Dealing
25th May 20224:13 pmRNSHolding(s) in Company
19th May 20223:57 pmRNSEBT Subscription & Total Voting Rights
13th May 20224:25 pmRNSDirectors/PDMRs Dealing - Replacement
12th May 20224:46 pmRNSDirectors/PDMRs Dealing
4th May 20224:16 pmRNSResult of AGM
4th May 20227:00 amRNSAGM Statement
17th Mar 20227:00 amRNSFull Year Results
14th Feb 20224:38 pmRNSNotice of Results
12th Jan 20227:00 amRNSFull Year Trading Update
21st Oct 20215:16 pmRNSDirectorate Appointment
2nd Sep 20217:00 amRNSHalf Year Results
13th Aug 20217:00 amRNSEquity Development Investor Webinar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.